Neuroleptic Malignant Syndrome during Perphenazine Treatment in A Patient with Head and Neck Cancer: A Case Report

Delay J. , Deniker P. Drug-induced extrapyramidal syndromes. In: Vinken P.J. , Bruyn G.W. , eds. Handbook of clinical neurology. Vol. 6. Diseases of the basal ganglia. New York: American Elsevier, 1968: 248–66.

Guerrero R.M. , Shifrar K.A. Diagnosis and treatment of neuroleptic malignant syndrome. Clin Pharm 1988; 7: 697–701.

Guze B.H. , Baxter L.R. Neuroleptic malignant syndrome. N Engl J Med 1985; 313: 163–6.

Wells A.J. , Sommi R.W. , Crimson M.L. Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review. Drug Intell Clin Pharm 1988; 22: 475–80.

Rosenberg M.R. , Green M. Neuroleptic malignant syndrome: review of response to therapy. Arch Intern Med 1989; 149: 1927–31.

Smego R.A. , Durack D.T. The neuroleptic malignant syndrome. Arch Intern Med 1982; 142: 1183–5.

Birkhimer L.J. , De Vane C.L. The neuroleptic malignant syndrome: presentation and treatment. Drug Intell Clin Pharm 1984; 18: 462–5.

Nielsen D. , Aunsholt N.A. , Anderson P.T. Neuroleptic malignant syndrome during perphenazine treatment. Pharmacol Toxicol 1987; 60: 221–2.

Shalev A. Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 1989; 50: 18–25.

Bronheim H. , Strain J.J. , Biller H.F. , Fulop G. Psychiatric consultation on an Otolaryngology Service. Gen Hosp Psychiatry 1989; 11: 95–102.

Setton I. , Hirsch D. , eds. Israeli Drug Compendium. Petah Tikvah: Medcom Ltd., 1986: 332–4.